Selected article for: "Cox proportional hazard regression analysis and proportional hazard"
Author: Poudel, Ayusha; Poudel, Yashasa; Adhikari, Anurag; Aryal, Barun Babu; Dangol, Debika; Bajracharya, Tamanna; Maharjan, Anil; Gautam, Rakshya
Title: D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19
  • Cord-id: gvz0zf7l
  • Document date: 2021_8_26
    • ID: gvz0zf7l
    Snippet: INTRODUCTION: Coronavirus Disease 2019 is a primarily respiratory illness that can cause thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in COVID-19, though optimal cutoff value for D-dimer to predict mortality has not yet been established. This study aims to assess the accuracy of admission D-dimer in the prognosis of COVID-19 and to establish the optimal cutoff D-dimer value to predict hospital mortality. METHODS: Clinical and laboratory parameters and ou
    Document: INTRODUCTION: Coronavirus Disease 2019 is a primarily respiratory illness that can cause thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in COVID-19, though optimal cutoff value for D-dimer to predict mortality has not yet been established. This study aims to assess the accuracy of admission D-dimer in the prognosis of COVID-19 and to establish the optimal cutoff D-dimer value to predict hospital mortality. METHODS: Clinical and laboratory parameters and outcomes of confirmed COVID-19 cases admitted to four hospitals in Kathmandu were retrospectively analyzed. Admitted COVID-19 cases with recorded D-dimer and definitive outcomes were included consecutively. D-dimer was measured using immunofluorescence assay and reported in Fibrinogen Equivalent Unit (μg/ml). The receiver operating characteristic curve was used to determine the accuracy of D-dimer in predicting mortality, and to calculate the optimal cutoff value, based on which patients were divided into two groups and predictive value of D-dimer for mortality was measured. RESULTS: 182 patients were included in the study out of which 34(18.7%) died during the hospital stay. The mean admission D-dimer among surviving patients was 1.067 μg/ml (±1.705 μg/ml), whereas that among patients who died was 3.208 μg/ml (±2.613 μg/ml). ROC curve for D-dimer and mortality gave an area under the curve of 0.807 (95% CI 0.728–0.886, p<0.001). Optimal cutoff value for D-dimer was 1.5 μg/ml (sensitivity 70.6%, specificity 78.4%). On Cox proportional hazards regression analysis, the unadjusted hazard ratio for high D-dimer was 6.809 (95% CI 3.249–14.268, p<0.001), and 5.862 (95% CI 2.751–12.489, p<0.001) when adjusted for age. CONCLUSION: D-dimer value on admission is an accurate biomarker for predicting mortality in patients with COVID-19. 1.5 μg/ml is the optimal cutoff value of admission D-dimer for predicting mortality in COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and adjusted hazard ratio: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and admission dimer: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and admission measure: 1
    • acute ards respiratory distress syndrome and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and low lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and lymphocyte platelet count: 1, 2, 3
    • adjusted hazard ratio and admission day: 1, 2, 3, 4, 5, 6, 7
    • adjusted hazard ratio and admission dimer: 1, 2, 3
    • adjusted hazard ratio and admission measure: 1
    • adjusted hazard ratio and admission time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • admission day and lmwh molecular weight heparin: 1, 2
    • admission day and low lmwh molecular weight heparin: 1, 2
    • admission day and lymphocyte platelet count: 1, 2, 3, 4
    • admission dimer and lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • admission dimer and low lmwh molecular weight heparin: 1, 2, 3, 4, 5, 6, 7
    • admission dimer and lymphocyte platelet count: 1, 2
    • admission time and lymphocyte platelet count: 1, 2, 3, 4, 5, 6, 7, 8, 9